Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Recruiting · NCT04104529 · Interventional (participants receive a specific treatment) · Lead sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
View the official record on ClinicalTrials.gov →Interventions studied
Biological collectiontumor collection
What this trial is about
Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age ≥ at 18 years old,
- Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,
- Patient treated as part of his treatment for:
- thyroid cancer,
- a neuroendocrine tumor or
- prostate cancer.
- Patient having accepted the complementary blood sample,
- Patient having given his informed, written and express consent.
Exclusion criteria
- Patient not affiliated to a social security scheme,
- Subject under tutelage, curatorship or safeguard of justice,
- Patient in an emergency situation
- Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,
- Pregnant and / or breastfeeding woman
Where it is running
4 locations listed.
- Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle - Montpellier, France
- Institut Universitaire du Cancer de Toulouse - Toulouse, France
- Hopital Haut Lévêque - Bordeaux, Aquitaine, France
- Hôpital LaTimone - Marseille, Bouches Du Rhône, France